Description

PharmaQo Multi Ester Tren 200 is a powerful injectable formulation delivering 200 mg/mL of a blend of Trenbolone Acetate, Trenbolone Enanthate, and Trenbolone Hexahydrobenzylcarbonate. This multi-ester combination is designed for research investigating sustained anabolic activity, nitrogen retention, and tissue preservation across both short- and long-duration phases.

The blend ensures rapid onset from the acetate and prolonged effects from the enanthate and hex esters, providing stable blood levels over extended periods.

Product Details:
Active Ingredients (per mL):

• Trenbolone Acetate

• Trenbolone Enanthate

• Trenbolone Hexahydrobenzylcarbonate

Total Concentration: 200 mg/mL

Form: Injectable solution (intramuscular)

Vial Size: 10 mL multidose vial

Pharmacokinetics:
The mixed esters provide a half-life range from ~1–3 days (acetate) to 7–14 days (enanthate, hex), enabling flexible research dosing schedules.

Usage Recommendations:

• Indications (Research Context): Investigational use in anabolic research, nitrogen retention, recovery, tissue-wasting models (not approved for human use)

• Typical Dosage (Research Use): 200–400 mg per week, depending on study design

• Monitoring: Cardiovascular markers, liver enzymes, androgenic effects, lipid profile

• Cycle/Duration: 8–12 weeks, following research protocol

Disclaimer:
This product is intended strictly for research and educational purposes. It is not for human consumption or therapeutic use. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with health risks. Always comply with local research regulations and ethical standards.